Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

AVITA Medical (RCEL) Net Margin (2018 - 2025)

AVITA Medical filings provide 8 years of Net Margin readings, the most recent being 12.63% for Q4 2025.

  • On a quarterly basis, Net Margin rose 5151.0% to 12.63% in Q4 2025 year-over-year; TTM through Dec 2025 was 33.28%, a 6372.0% increase, with the full-year FY2025 number at 68.55%, up 2823.0% from a year prior.
  • Net Margin hit 12.63% in Q4 2025 for AVITA Medical, up from 77.29% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 265.07% in Q4 2023 to a low of 168.03% in Q1 2024.
  • Median Net Margin over the past 5 years was 71.64% (2025), compared with a mean of 58.56%.
  • Biggest five-year swings in Net Margin: surged 32311bps in 2023 and later tumbled -32921bps in 2024.
  • AVITA Medical's Net Margin stood at 84.73% in 2021, then skyrocketed by 31bps to 58.04% in 2022, then skyrocketed by 557bps to 265.07% in 2023, then plummeted by -124bps to 64.14% in 2024, then soared by 80bps to 12.63% in 2025.
  • The last three reported values for Net Margin were 12.63% (Q4 2025), 77.29% (Q3 2025), and 53.86% (Q2 2025) per Business Quant data.